SEC Filings

Filing date	Form	Description	View
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002148.pdf 0001179110-20-002148.rtf 0001179110-20-002148.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002146.pdf 0001179110-20-002146.rtf 0001179110-20-002146.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002154.pdf 0001179110-20-002154.rtf 0001179110-20-002154.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002158.pdf 0001179110-20-002158.rtf 0001179110-20-002158.xls
02/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-002156.pdf 0001179110-20-002156.rtf 0001179110-20-002156.xls
02/18/20	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001387131-20-001890.pdf 0001387131-20-001890.rtf 0001387131-20-001890.xls
02/13/20	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-019582.pdf 0001104659-20-019582.rtf 0001104659-20-019582.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
02/12/20	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-20-018589.pdf 0001104659-20-018589.rtf
02/12/20	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-20-000842.pdf 0001047469-20-000842.rtf 0001047469-20-000842.xls
02/10/20	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-20-000779.pdf 0001047469-20-000779.rtf 0001047469-20-000779.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.